NRD
HIMS icon

Nebula Research & Development’s Hims & Hers Health HIMS Stock Holding History

Nebula Research & Development’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-196,814
Closed -$3.63M – 986
2024
Q3 		$3.63M Buy
196,814
+165,102
+521% +$2.96M 0.43% 16
2024
Q2 		$640K Buy
31,712
+18,413
+138% +$306K 0.1% 354
2024
Q1 		$206K Sell
13,299
-1,702
-11% -$19.2K 0.04% 641
2023
Q4 		$134K Sell
15,001
-23,179
-61% -$171K 0.04% 585
2023
Q3 		$240K Buy
+38,180
New +$284K 0.13% 347

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nebula Research & Development's HIMS Position: Q4 2024 in Review

Nebula Research & Development sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 196,814 shares — an estimated $3.63M sold.

Nebula Research & Development first reported a position in HIMS in Q3 2023 and held it in 5 quarters. The position peaked at $3.63M in Q3 2024. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

  • Nebula Research & Development reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 196,814 Hims & Hers Health shares in Q4 2024, an estimated $3.63M.
  • Nebula Research & Development first reported a position in Hims & Hers Health in Q3 2023 and held it in 5 quarters.
  • Nebula Research & Development's Hims & Hers Health position peaked at $3.63M in Q3 2024.
  • 394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.